Prognostic significance of prostaglandin E2 production in fresh tissues of head and neck cancer patients

This publication has 13 references indexed in Scilit:

• Administration of a Prostaglandin Synthetase Inhibitor Associated With an Increased Immune Cell Infiltrate in Squamous Cell Carcinoma of the Head and Neck
  JAMA Otolaryngology–Head & Neck Surgery, 1992
• Increased production of tumor necrosis factor and prostaglandin E2 by monocytes in cancer patients and its unique modulation by their plasma
  Cancer Immunology, Immunotherapy, 1987
• Characterization of cells from invaded lymph nodes in patients with solid tumors. Lymphokine requirement for tumor-specific lymphoproliferative response.
  The Journal of Experimental Medicine, 1987
• Prostaglandin E₂ of the Upper Aerodigestive Tract
  Annals of Otology, Rhinology & Laryngology, 1987
• Neck Node Immunoreactivity in Head and Neck Carcinoma
  Otolaryngology -- Head and Neck Surgery, 1986
• Indomethacin therapy abrogates the prostaglandin-mediated suppression of natural killer activity in tumor-bearing mice and prevents tumor metastasis
  Cellular Immunology, 1986
• Arachidonic Acid Metabolites in Cutaneous Carcinomas
  Archives of Dermatology, 1986
• Cancer and the prostaglandins: a mini review on cancer research
  Journal of Oral Pathology & Medicine, 1985
• Excessive Prostaglandin E2 Production by Suppressor Monocytes in Head and Neck Cancer Patients
  Annals of Surgery, 1982
• Immunobiology of head and neck cancer: Basic concepts
  Head & Neck Surgery, 1979